PSEUDOMONAS AERUGINOSA INFECTION
Clinical trials for PSEUDOMONAS AERUGINOSA INFECTION explained in plain language.
Never miss a new study
Get alerted when new PSEUDOMONAS AERUGINOSA INFECTION trials appear
Sign up with your email to follow new studies for PSEUDOMONAS AERUGINOSA INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Virus cocktail targets superbug pneumonia in first human test
Disease control Not yet recruitingThis early-stage trial tests MP101, a mix of two viruses that attack bacteria (phages), in 18 adults with Pseudomonas aeruginosa pneumonia. Participants receive a single dose of MP101 or a placebo alongside standard antibiotics. The main goal is to check safety and how the body h…
Matched conditions: PSEUDOMONAS AERUGINOSA INFECTION
Phase: PHASE1 • Sponsor: MicrobiotiX Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Virus cocktail takes on superbugs in cystic fibrosis trial
Disease control Not yet recruitingThis early-stage study tests whether adding specially-made viruses (phages) to standard antibiotics can safely treat stubborn lung infections in adults with cystic fibrosis. About 30 participants will receive a 7-day course of both treatments. The main goal is to check safety, bu…
Matched conditions: PSEUDOMONAS AERUGINOSA INFECTION
Phase: PHASE1 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Personalized antibiotic dosing could save lives in the ICU
Knowledge-focused Not yet recruitingThis study aims to find the best way to dose the antibiotic ceftazidime for patients in intensive care with serious infections. Many ICU patients don't get enough of the drug because their bodies process it differently. The researchers will test a personalized dosing plan to keep…
Matched conditions: PSEUDOMONAS AERUGINOSA INFECTION
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Saint Etienne • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC